(S)-3-Aminotetrahydrofuran hydrochloride, 95.0%, 25g

2-(4-Bromo-phenyl)-pyrrolidine, 97.0%, 1g

3-METHOXY-9H-XANTHEN-9-ONE, 90.0%, 2g

4-Bromo-2,6-dimethylphenylboronic acid, 97%, 1g

1-Methyl-3-(propan-2-yloxy)benzene, 98.0%, 500mg

Ethyl 4-(4-heptyloxyphenyl)-4-oxobutyrate, 97.0%, 1g

1-(4-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)-3-(p-tolyl)urea, 98%, 250mg

7-Chloro-4-methyl-1H-pyrrolo[2,3-c]pyridine, 95.0%, 250mg

6-(4-Chlorophenyl)-6-oxohexanenitrile, 97.0%, 1g

2,4-Difluoro-6-nitroaniline>98.0%(GC)5g

2-OXO-1,2-DIHYDRO-[1,8]NAPHTHYRIDINE-3-CARBOXYLIC ACID ETHYL ESTER, 95.0%, 250mg

METHYL 2-AMINOBENZO[D]THIAZOLE-5-CARBOXYLATE, 97.0%, 250mg

GC capillary column ROTI®Cap-1, 50 m, 0.25 mm, 0.50 µm, 1 Piece(s)